The US multicenter double-blind, randomized, phase III trial of thymoglobulin versus Atgam in the treatment of acute graft rejection episodes following renal transplantation: Rationale for study design

T. J. Schroeder, L. W. Moore, L. W. Gaber, A. O. Gaber, M. R. First

Research output: Contribution to journalArticlepeer-review

4 Scopus citations
Original languageEnglish (US)
Pages (from-to)1S-6S
JournalTransplantation Proceedings
Issue number3 SUPPL. 2
StatePublished - May 1999

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this